Drug Topics July 11, 2025
Brian Nowosielski, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joins Drug Topics to discuss her extensive background in managing patients’ insulin regimens.

From fast-acting and long-acting insulins to those requiring a meal, the standards of care for insulin delivery have changed over the years as researchers aim to develop insulin that best regulates the blood glucose of patients with diabetes.

“We have certainly made a lot of advances,” Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, told Drug Topics. “What I would almost ultimately love to see is a truly glucose-targeted insulin that just works when the glucose is high, and is truly physiologic, so that someone doesn’t have hypoglycemia or is not at risk of hypoglycemia.”

Isaacs has an extensive career in...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Interview / Q&A, Pharma, Pharma / Biotech, Trends
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety

Share Article